JP2001526637A5 - - Google Patents

Download PDF

Info

Publication number
JP2001526637A5
JP2001526637A5 JP1998538281A JP53828198A JP2001526637A5 JP 2001526637 A5 JP2001526637 A5 JP 2001526637A5 JP 1998538281 A JP1998538281 A JP 1998538281A JP 53828198 A JP53828198 A JP 53828198A JP 2001526637 A5 JP2001526637 A5 JP 2001526637A5
Authority
JP
Japan
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP1998538281A
Other languages
English (en)
Japanese (ja)
Other versions
JP4380800B2 (ja
JP2001526637A (ja
Filing date
Publication date
Priority claimed from GBGB9704809.4A external-priority patent/GB9704809D0/en
Priority claimed from GBGB9722232.7A external-priority patent/GB9722232D0/en
Priority claimed from GBGB9724263.0A external-priority patent/GB9724263D0/en
Priority claimed from GBGB9724712.6A external-priority patent/GB9724712D0/en
Application filed filed Critical
Priority claimed from PCT/GB1998/000675 external-priority patent/WO1998039003A1/en
Publication of JP2001526637A publication Critical patent/JP2001526637A/ja
Publication of JP2001526637A5 publication Critical patent/JP2001526637A5/ja
Application granted granted Critical
Publication of JP4380800B2 publication Critical patent/JP4380800B2/ja
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

JP53828198A 1997-03-07 1998-03-06 マラリアの処置のための(+)メフロキンの使用 Expired - Lifetime JP4380800B2 (ja)

Applications Claiming Priority (9)

Application Number Priority Date Filing Date Title
GBGB9704809.4A GB9704809D0 (en) 1997-03-07 1997-03-07 Chemical compounds
GB9704809.4 1997-03-07
GB9722232.7 1997-10-21
GBGB9722232.7A GB9722232D0 (en) 1997-10-21 1997-10-21 Chemical compounds
GB9724263.0 1997-11-17
GBGB9724263.0A GB9724263D0 (en) 1997-11-17 1997-11-17 Chemical compounds
GBGB9724712.6A GB9724712D0 (en) 1997-11-21 1997-11-21 Chemical compounds
GB9724712.6 1997-11-21
PCT/GB1998/000675 WO1998039003A1 (en) 1997-03-07 1998-03-06 Use of (+)mefloquine for the treatment of malaria

Publications (3)

Publication Number Publication Date
JP2001526637A JP2001526637A (ja) 2001-12-18
JP2001526637A5 true JP2001526637A5 (enExample) 2005-11-10
JP4380800B2 JP4380800B2 (ja) 2009-12-09

Family

ID=27451612

Family Applications (1)

Application Number Title Priority Date Filing Date
JP53828198A Expired - Lifetime JP4380800B2 (ja) 1997-03-07 1998-03-06 マラリアの処置のための(+)メフロキンの使用

Country Status (10)

Country Link
US (1) US6664397B1 (enExample)
EP (1) EP0966285B1 (enExample)
JP (1) JP4380800B2 (enExample)
AT (1) ATE225177T1 (enExample)
AU (1) AU730818B2 (enExample)
DE (1) DE69808440T2 (enExample)
DK (1) DK0966285T3 (enExample)
ES (1) ES2185153T3 (enExample)
PT (1) PT966285E (enExample)
WO (1) WO1998039003A1 (enExample)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0975345A1 (en) * 1997-11-26 2000-02-02 Cerebrus Pharmaceuticals Limited (-)-mefloquine to block purinergic receptors and to treat movement or neurodegenerative disorders
GB0021776D0 (en) 2000-09-05 2000-10-18 Arakis Ltd The treatment of inflammatory disorders
GB0406014D0 (en) * 2004-03-17 2004-04-21 Arakis Ltd Pharmaceutical composition and use
US20070032480A1 (en) * 2005-06-14 2007-02-08 The Johns Hopkins University Treatment of ischemia-induced arrhythmias
RU2008135762A (ru) * 2006-02-16 2010-03-27 Де МакЛин Хоспитал Корпорейшн (US) Способы и композиции для лечения болезни паркинсона
US20110039888A1 (en) * 2008-04-21 2011-02-17 Coltart Don M Asymmetric alpha functionalization and alpha, alpha bisfunctionalization of aldehydes and ketones
US8293783B2 (en) * 2009-03-24 2012-10-23 National University Of Singapore Use of artemisinin derivatives for the treatment of asthma and chronic obstructive pulmonary disease (COPD)
US8716265B2 (en) 2010-11-18 2014-05-06 Jenrin Discovery, Inc. 4-quinolinemethanols as anti-malarial agents
EP2487157A1 (en) 2011-02-11 2012-08-15 Université de Picardie Jules Verne Enantioselective synthesis method of 4-aminoalcoholquinoline derivatives and the use
RU2015105407A (ru) * 2012-08-09 2016-10-10 Кэн-Файт Биофарма Лтд. Лиганды аденозинового рецептора а3 для применения при лечении половой дисфункции
CN103304538B (zh) * 2013-06-21 2014-12-24 中国人民解放军第四军医大学 右旋甲氟喹的合成
CN107149601B (zh) * 2017-05-25 2020-04-17 中国中医科学院中药研究所 青蒿素类化合物在制备治疗神经病理性疼痛和/或并发症的药物中的应用
US11220482B2 (en) 2017-11-03 2022-01-11 Universite Amiens Picardie Jules Verne Aminopyridinemethanol compounds and their use
CN110507646A (zh) * 2019-09-12 2019-11-29 广州中医药大学(广州中医药研究院) 青蒿素衍生物在制备抗焦虑症的药物或缓解焦虑症的食品中的应用

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3536809A (en) 1969-02-17 1970-10-27 Alza Corp Medication method
US3598123A (en) 1969-04-01 1971-08-10 Alza Corp Bandage for administering drugs
US3630200A (en) 1969-06-09 1971-12-28 Alza Corp Ocular insert
US3845770A (en) 1972-06-05 1974-11-05 Alza Corp Osmatic dispensing device for releasing beneficial agent
US3916899A (en) 1973-04-25 1975-11-04 Alza Corp Osmotic dispensing device with maximum and minimum sizes for the passageway
US4008719A (en) 1976-02-02 1977-02-22 Alza Corporation Osmotic system having laminar arrangement for programming delivery of active agent
DE2940443A1 (de) 1979-10-05 1981-04-16 Basf Ag, 6700 Ludwigshafen Verfahren zur herstellung von erythro-(alpha)-2-piperidyl-2,8-bis-(trifluormethyl)-4-chinolin-methanol
GB8322007D0 (en) 1983-08-16 1983-09-21 Wellcome Found Pharmaceutical delivery system
US4769027A (en) 1984-08-15 1988-09-06 Burroughs Wellcome Co. Delivery system

Similar Documents

Publication Publication Date Title
JP2000510751A5 (enExample)
JP2000509942A5 (enExample)
JP2000507042A5 (enExample)
JP2002513527A5 (enExample)
JP2001510679A5 (enExample)
JP2000507369A5 (enExample)
JP2000507433A5 (enExample)
JP2002505699A5 (enExample)
JP2000508866A5 (enExample)
JP2001513266A5 (enExample)
JP2000510793A5 (enExample)
JP2000508022A5 (enExample)
JP2002504992A5 (enExample)
JP2000508841A5 (enExample)
JP2000508680A5 (enExample)
JP2002501526A5 (enExample)
JP2001512319A5 (enExample)
JP2000510247A5 (enExample)
JP2000510969A5 (enExample)
JP2000508102A5 (enExample)
JP2000508836A5 (enExample)
JP2001518128A5 (enExample)
JP2000507434A5 (enExample)
JP2000508880A5 (enExample)
JP2000509958A5 (enExample)